
Sign up to save your podcasts
Or


Norbert Stefan discusses a small but positive trial of a new drug in people with non-alcoholic fatty liver disease.
By The Lancet Diabetes & EndocrinologyNorbert Stefan discusses a small but positive trial of a new drug in people with non-alcoholic fatty liver disease.